Glass House Brands Inc
GLAS
NYSE·Healthcare·Drug Manufacturers - Specialty & Generic·Mkt cap $682.1M
$8.81
▲ +2.44%
P/E
-48.94
Mkt Cap
$682.1M
52-Wk Range
$8.41–$13.19
52-Week Range
$8.41 - $13.19
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 22.0% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
No bull reasons captured for this rating yet.
Bear Case
1 risk
- Low volatility (beta 0.5).
Growth
Strong growth ahead
Value
Deep value opportunity - significant discount to sector peers
Momentum
Falling
-33.0% over 3m
Quality
Stable
Mixed fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying GLAS right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 11, 2026
AUG 12, 2026
Reported EPS of -$0.08 vs -$0.08 consensus (-4.3% surprise). Revenue of $47.0M vs $54.4M expected (-13.6%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-4.3%
Revenue trend · last 1Q
—
Q1 26
$38.9M
Margins · last 1Q
Profit
-39.9%
Wall Street consensus
1 analyst · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Lake Street · Jul 13, 2026
vs Industry
How GLAS stacks vs Drug Manufacturers - Specialty & Generic
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.